Table 1 The clinical characteristics of placentas samples and blood samples used in the study

From: Decreased ALCAM expression and promoter hypermethylation is associated with preeclampsia

Characteristics

Placentas samples

Blood samples

CTL (n = 53)

PE (n = 47)

P-value

CTL (n = 100)

PE (n = 100)

P -value

Age, year

32.38 ± 5.20

31.26 ± 5.35

0.288

30.96 ± 3.87

30.73 ± 5.36

0.739

BMI, kg/m2

28.14 ± 3.88

31.88 ± 4.63

<0.001

21.67 ± 3.14

23.57 ± 3.64

0.002

Age of menarche, year

14.10 ± 0.95

14.10 ± 1.57

0.981

13.31 ± 1.32

13.53 ± 1.60

0.374

Gestational age, week

39.12 ± 1.69

35.63 ± 2.82

<0.001

39.68 ± 0.97

34.35 ± 3.54

<0.001

SBP, mmHg

121.10 ± 11.55

161.18 ± 12.72

<0.001

117.21 ± 10.10

166.68 ± 17.17

<0.001

DBP, mmHg

74.67 ± 7.31

103.97 ± 10.51

<0.001

71.76 ± 8.78

105.21 ± 14.80

<0.001

Fetal weight, g

3280.67 ± 522.99

2495.00 ± 824.88

<0.001

3457.45 ± 313.97

2110.35 ± 962.87

<0.001

  1. All data are given as mean ± standard deviation
  2. CTL control, PE preeclampsia
Back to article page